Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armenteros is an AI-driven biotechnology company specializing in the design and optimization of protein secretion. Founded by Jose Juan Almagro Armenteros, the creator of the industry-standard SignalP software, the company leverages deep learning to decode the complex signals that govern how proteins are transported and secreted by cells. By engineering optimized signal peptides and secretion motifs, Armenteros aims to significantly increase the yields and stability of recombinant proteins, including monoclonal antibodies and enzymes. Their platform technology addresses critical bottlenecks in biomanufacturing and the development of difficult-to-express therapeutic proteins. The company operates at the intersection of generative AI and synthetic biology to expand the functional universe of engineered biomolecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armenteros.